Literature DB >> 24523840

How to treat the frail elderly: The challenge of multimorbidity and polypharmacy.

Cara Tannenbaum1.   

Abstract

THE PHARMACOLOGIC MANAGEMENT OF LOWER URINARY TRACT SYMPTOMS IN FRAIL OLDER ADULTS IS COMPLICATED BY TWO KEY CONSIDERATIONS: the increased likelihood of comorbidities and the increased likelihood of polypharmacy. This brief review summarizes how these factors may impact treatment choices in this population.

Year:  2013        PMID: 24523840      PMCID: PMC3919194          DOI: 10.5489/cuaj.1619

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  13 in total

1.  Comorbidities associated with bladder dysfunction.

Authors:  C Tannenbaum; M Gray; S Hoffstetter; L Cardozo
Journal:  Int J Clin Pract       Date:  2013-02       Impact factor: 2.503

Review 2.  Overactive bladder drugs and constipation: a meta-analysis of randomized, placebo-controlled trials.

Authors:  Patrick D Meek; Samuel D Evang; Mina Tadrous; Dianne Roux-Lirange; Darren M Triller; Bora Gumustop
Journal:  Dig Dis Sci       Date:  2010-07-02       Impact factor: 3.199

3.  Incontinence in the frail elderly: report from the 4th International Consultation on Incontinence.

Authors:  Catherine E DuBeau; George A Kuchel; Theodore Johnson; Mary H Palmer; Adrian Wagg
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

4.  Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses.

Authors:  Nora Buser; Sandra Ivic; Thomas M Kessler; Alfons G H Kessels; Lucas M Bachmann
Journal:  Eur Urol       Date:  2012-09-07       Impact factor: 20.096

Review 5.  Systematic review and meta-analysis: do clinical trials testing antimuscarinic agents for overactive bladder adequately measure central nervous system adverse events?

Authors:  Amélie Paquette; Pauline Gou; Cara Tannenbaum
Journal:  J Am Geriatr Soc       Date:  2011-06-30       Impact factor: 5.562

6.  Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes.

Authors:  Kaycee M Sink; Joseph Thomas; Huiping Xu; Bruce Craig; Steven Kritchevsky; Laura P Sands
Journal:  J Am Geriatr Soc       Date:  2008-04-01       Impact factor: 5.562

7.  Cardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladder.

Authors:  Karl-Erik Andersson; Chaitanya Sarawate; Kristijan H Kahler; Elizabeth L Stanley; Amit S Kulkarni
Journal:  BJU Int       Date:  2009-11-17       Impact factor: 5.588

8.  Randomized, placebo-controlled trial of the cognitive effect, safety, and tolerability of oral extended-release oxybutynin in cognitively impaired nursing home residents with urge urinary incontinence.

Authors:  Thomas E Lackner; Jean F Wyman; Teresa C McCarthy; Melinda Monigold; Cynthia Davey
Journal:  J Am Geriatr Soc       Date:  2008-04-09       Impact factor: 5.562

Review 9.  Frailty in elderly people.

Authors:  Andrew Clegg; John Young; Steve Iliffe; Marcel Olde Rikkert; Kenneth Rockwood
Journal:  Lancet       Date:  2013-02-08       Impact factor: 79.321

10.  Prevalence of commonly prescribed medications potentially contributing to urinary symptoms in a cohort of older patients seeking care for incontinence.

Authors:  Mandavi Kashyap; Le Mai Tu; Cara Tannenbaum
Journal:  BMC Geriatr       Date:  2013-06-10       Impact factor: 3.921

View more
  1 in total

1.  Urologic symptoms and burden of frailty and geriatric conditions in older men: the Aging Study of PyeongChang Rural Area.

Authors:  Il-Young Jang; Chang Ki Lee; Hee-Won Jung; Sang Soo Yu; Young Soo Lee; Eunju Lee; Dae Hyun Kim
Journal:  Clin Interv Aging       Date:  2018-02-20       Impact factor: 4.458

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.